Megadeal rumors swirl around Bayer amid 'encouraging' Q1
This article was originally published in Scrip
Executive Summary
Bayer has reported a first-quarter increase in earnings which beat analyst estimates due to surprise growth in its material science unit, which – it is rumored - is up for sale with a potential €8bn price tag.